nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ADRA1D—polycystic ovary syndrome	0.357	0.412	CbGaD
Silodosin—ADRA1B—polycystic ovary syndrome	0.305	0.352	CbGaD
Silodosin—ADRA1A—polycystic ovary syndrome	0.205	0.237	CbGaD
Silodosin—Tamsulosin—ADRA1D—polycystic ovary syndrome	0.00255	0.412	CrCbGaD
Silodosin—ABCB4—adrenal cortex—polycystic ovary syndrome	0.00223	0.181	CbGeAlD
Silodosin—Tamsulosin—ADRA1B—polycystic ovary syndrome	0.00218	0.352	CrCbGaD
Silodosin—ABCB4—adrenal gland—polycystic ovary syndrome	0.00161	0.131	CbGeAlD
Silodosin—ABCB4—vagina—polycystic ovary syndrome	0.00149	0.121	CbGeAlD
Silodosin—Tamsulosin—ADRA1A—polycystic ovary syndrome	0.00147	0.237	CrCbGaD
Silodosin—ABCB4—endocrine gland—polycystic ovary syndrome	0.00139	0.113	CbGeAlD
Silodosin—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00123	0.1	CcSEcCtD
Silodosin—CYP3A4—urine—polycystic ovary syndrome	0.00117	0.0954	CbGeAlD
Silodosin—Nasal congestion—Metformin—polycystic ovary syndrome	0.000796	0.0647	CcSEcCtD
Silodosin—UGT2B7—endocrine gland—polycystic ovary syndrome	0.000713	0.058	CbGeAlD
Silodosin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00067	0.0544	CcSEcCtD
Silodosin—Breast disorder—Metformin—polycystic ovary syndrome	0.000656	0.0533	CcSEcCtD
Silodosin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000649	0.0527	CcSEcCtD
Silodosin—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000565	0.046	CbGeAlD
Silodosin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000529	0.043	CcSEcCtD
Silodosin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000466	0.0378	CcSEcCtD
Silodosin—Angiopathy—Metformin—polycystic ovary syndrome	0.000455	0.037	CcSEcCtD
Silodosin—Immune system disorder—Metformin—polycystic ovary syndrome	0.000453	0.0368	CcSEcCtD
Silodosin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000452	0.0368	CcSEcCtD
Silodosin—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000417	0.034	CbGeAlD
Silodosin—Syncope—Metformin—polycystic ovary syndrome	0.000392	0.0318	CcSEcCtD
Silodosin—Palpitations—Metformin—polycystic ovary syndrome	0.000386	0.0314	CcSEcCtD
Silodosin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000384	0.0312	CcSEcCtD
Silodosin—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000374	0.0305	CbGeAlD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000369	0.03	CcSEcCtD
Silodosin—Shock—Metformin—polycystic ovary syndrome	0.000351	0.0285	CcSEcCtD
Silodosin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00035	0.0284	CcSEcCtD
Silodosin—Skin disorder—Metformin—polycystic ovary syndrome	0.000346	0.0281	CcSEcCtD
Silodosin—Hypotension—Metformin—polycystic ovary syndrome	0.000333	0.0271	CcSEcCtD
Silodosin—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000325	0.0264	CbGeAlD
Silodosin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000308	0.025	CcSEcCtD
Silodosin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000292	0.0237	CcSEcCtD
Silodosin—Urticaria—Metformin—polycystic ovary syndrome	0.000283	0.023	CcSEcCtD
Silodosin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000282	0.0229	CcSEcCtD
Silodosin—ABCB1—embryo—polycystic ovary syndrome	0.000268	0.0218	CbGeAlD
Silodosin—Asthenia—Metformin—polycystic ovary syndrome	0.000256	0.0208	CcSEcCtD
Silodosin—Pruritus—Metformin—polycystic ovary syndrome	0.000252	0.0205	CcSEcCtD
Silodosin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000244	0.0198	CcSEcCtD
Silodosin—Dizziness—Metformin—polycystic ovary syndrome	0.000236	0.0192	CcSEcCtD
Silodosin—Rash—Metformin—polycystic ovary syndrome	0.000225	0.0183	CcSEcCtD
Silodosin—Dermatitis—Metformin—polycystic ovary syndrome	0.000225	0.0182	CcSEcCtD
Silodosin—Headache—Metformin—polycystic ovary syndrome	0.000223	0.0181	CcSEcCtD
Silodosin—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00022	0.0179	CbGeAlD
Silodosin—Nausea—Metformin—polycystic ovary syndrome	0.000212	0.0172	CcSEcCtD
Silodosin—ABCB1—endometrium—polycystic ovary syndrome	0.000196	0.016	CbGeAlD
Silodosin—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000194	0.0158	CbGeAlD
Silodosin—ABCB1—uterus—polycystic ovary syndrome	0.000181	0.0147	CbGeAlD
Silodosin—ABCB1—pituitary gland—polycystic ovary syndrome	0.000178	0.0145	CbGeAlD
Silodosin—ABCB1—adipose tissue—polycystic ovary syndrome	0.000177	0.0144	CbGeAlD
Silodosin—ABCB1—adrenal gland—polycystic ovary syndrome	0.000159	0.0129	CbGeAlD
Silodosin—ABCB1—female gonad—polycystic ovary syndrome	0.000148	0.012	CbGeAlD
Silodosin—ABCB1—vagina—polycystic ovary syndrome	0.000147	0.012	CbGeAlD
Silodosin—ABCB1—endocrine gland—polycystic ovary syndrome	0.000138	0.0112	CbGeAlD
Silodosin—ADRA1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.82e-05	0.000275	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NAMPT—polycystic ovary syndrome	2.74e-05	0.000267	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.73e-05	0.000267	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP11A1—polycystic ovary syndrome	2.71e-05	0.000264	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	2.7e-05	0.000263	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.68e-05	0.000261	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	2.68e-05	0.000261	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	2.68e-05	0.000261	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FSHR—polycystic ovary syndrome	2.66e-05	0.000259	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.64e-05	0.000257	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	2.62e-05	0.000255	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—POMC—polycystic ovary syndrome	2.6e-05	0.000253	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—INHBB—polycystic ovary syndrome	2.59e-05	0.000253	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.58e-05	0.000252	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	2.58e-05	0.000251	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKR1C3—polycystic ovary syndrome	2.56e-05	0.000249	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP17A1—polycystic ovary syndrome	2.52e-05	0.000245	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	2.52e-05	0.000245	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.5e-05	0.000244	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.5e-05	0.000243	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.43e-05	0.000237	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.43e-05	0.000237	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.42e-05	0.000236	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FST—polycystic ovary syndrome	2.37e-05	0.000231	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.36e-05	0.00023	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.36e-05	0.00023	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.35e-05	0.000229	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.34e-05	0.000228	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LHB—polycystic ovary syndrome	2.31e-05	0.000225	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.31e-05	0.000225	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	2.3e-05	0.000224	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.26e-05	0.00022	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	2.23e-05	0.000217	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	2.23e-05	0.000217	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	2.2e-05	0.000215	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.19e-05	0.000213	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.18e-05	0.000213	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—TH—polycystic ovary syndrome	2.18e-05	0.000212	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SCT—polycystic ovary syndrome	2.17e-05	0.000211	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	2.16e-05	0.00021	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.16e-05	0.00021	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.15e-05	0.00021	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.14e-05	0.000209	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.14e-05	0.000208	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.13e-05	0.000207	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—SLC2A4—polycystic ovary syndrome	2.12e-05	0.000207	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.1e-05	0.000204	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.07e-05	0.000202	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.07e-05	0.000201	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FGF18—polycystic ovary syndrome	2.03e-05	0.000198	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.02e-05	0.000197	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.02e-05	0.000196	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RBP4—polycystic ovary syndrome	2.01e-05	0.000196	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2e-05	0.000195	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP19A1—polycystic ovary syndrome	1.99e-05	0.000194	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.98e-05	0.000193	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.98e-05	0.000193	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	1.96e-05	0.000191	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	1.96e-05	0.000191	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	1.95e-05	0.00019	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.94e-05	0.000189	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	1.92e-05	0.000187	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	1.92e-05	0.000187	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	1.9e-05	0.000186	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.9e-05	0.000185	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—YAP1—polycystic ovary syndrome	1.88e-05	0.000183	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.87e-05	0.000183	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	1.87e-05	0.000182	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GAB1—polycystic ovary syndrome	1.85e-05	0.000181	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.84e-05	0.00018	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.84e-05	0.000179	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.82e-05	0.000177	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.81e-05	0.000177	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	1.8e-05	0.000175	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	1.78e-05	0.000173	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.77e-05	0.000173	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—INSR—polycystic ovary syndrome	1.77e-05	0.000173	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	1.77e-05	0.000172	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	1.75e-05	0.00017	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.74e-05	0.000169	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.74e-05	0.000169	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	1.74e-05	0.000169	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.72e-05	0.000168	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.71e-05	0.000167	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	1.7e-05	0.000166	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	1.69e-05	0.000165	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.69e-05	0.000165	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.69e-05	0.000164	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	1.68e-05	0.000164	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.68e-05	0.000164	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	1.67e-05	0.000163	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.66e-05	0.000162	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.66e-05	0.000162	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.66e-05	0.000162	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.65e-05	0.00016	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PGR—polycystic ovary syndrome	1.64e-05	0.00016	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.61e-05	0.000157	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.61e-05	0.000157	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.61e-05	0.000157	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.61e-05	0.000157	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	1.61e-05	0.000157	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.6e-05	0.000156	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.58e-05	0.000154	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	1.56e-05	0.000152	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	1.54e-05	0.00015	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GHRL—polycystic ovary syndrome	1.53e-05	0.000149	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PLAT—polycystic ovary syndrome	1.53e-05	0.000149	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.52e-05	0.000148	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.51e-05	0.000147	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.5e-05	0.000147	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	1.5e-05	0.000146	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.5e-05	0.000146	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.48e-05	0.000145	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.48e-05	0.000144	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.47e-05	0.000143	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.47e-05	0.000143	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.46e-05	0.000142	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ATF1—polycystic ovary syndrome	1.46e-05	0.000142	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.44e-05	0.00014	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.42e-05	0.000138	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.42e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.41e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.4e-05	0.000136	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.39e-05	0.000135	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.38e-05	0.000134	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.37e-05	0.000134	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.37e-05	0.000134	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.37e-05	0.000133	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.36e-05	0.000133	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NGFR—polycystic ovary syndrome	1.34e-05	0.000131	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—POMC—polycystic ovary syndrome	1.33e-05	0.00013	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PRL—polycystic ovary syndrome	1.33e-05	0.00013	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.31e-05	0.000128	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.31e-05	0.000127	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.28e-05	0.000125	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.28e-05	0.000125	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.27e-05	0.000123	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.27e-05	0.000123	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.26e-05	0.000123	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.24e-05	0.000121	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.24e-05	0.000121	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.22e-05	0.000119	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.22e-05	0.000119	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	1.21e-05	0.000118	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.21e-05	0.000118	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.21e-05	0.000118	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	1.2e-05	0.000117	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—INS—polycystic ovary syndrome	1.19e-05	0.000116	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.18e-05	0.000115	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.17e-05	0.000114	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GNAS—polycystic ovary syndrome	1.17e-05	0.000114	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.15e-05	0.000112	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.14e-05	0.000111	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.12e-05	0.00011	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.12e-05	0.00011	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.12e-05	0.000109	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.11e-05	0.000109	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.11e-05	0.000108	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.1e-05	0.000108	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.1e-05	0.000108	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	1.09e-05	0.000107	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.09e-05	0.000106	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.08e-05	0.000106	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.07e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.06e-05	0.000104	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.06e-05	0.000104	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.05e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.05e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.04e-05	0.000101	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.04e-05	0.000101	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.02e-05	9.97e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.01e-05	9.84e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	9.9e-06	9.65e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	9.84e-06	9.59e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	9.81e-06	9.56e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	9.72e-06	9.47e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	9.54e-06	9.3e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.46e-06	9.22e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	9.39e-06	9.15e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	9.38e-06	9.14e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.31e-06	9.07e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.27e-06	9.03e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.26e-06	9.02e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	9.18e-06	8.94e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.09e-06	8.86e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.84e-06	8.62e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	8.63e-06	8.41e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.22e-06	8.01e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	8.19e-06	7.98e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.12e-06	7.92e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	8.07e-06	7.87e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.06e-06	7.86e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.9e-06	7.7e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	7.88e-06	7.68e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.88e-06	7.68e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	7.84e-06	7.64e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	7.78e-06	7.59e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.63e-06	7.44e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	7.62e-06	7.42e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	7.58e-06	7.39e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	7.58e-06	7.39e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.43e-06	7.24e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.2e-06	7.02e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.02e-06	6.85e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.91e-06	6.74e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.8e-06	6.63e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	6.79e-06	6.62e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	6.77e-06	6.59e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.63e-06	6.46e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.56e-06	6.39e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	6.54e-06	6.38e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	6.51e-06	6.34e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.32e-06	6.16e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.3e-06	6.14e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.29e-06	6.13e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.29e-06	6.13e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.22e-06	6.06e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.04e-06	5.88e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.99e-06	5.84e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.98e-06	5.83e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.88e-06	5.73e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	5.81e-06	5.66e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	5.8e-06	5.65e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.78e-06	5.64e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	5.78e-06	5.63e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.59e-06	5.45e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.59e-06	5.44e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.58e-06	5.44e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.31e-06	5.17e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.01e-06	4.88e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.95e-06	4.83e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.87e-06	4.75e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.81e-06	4.69e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.58e-06	4.46e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.53e-06	4.41e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.47e-06	4.35e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.44e-06	4.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.28e-06	4.17e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.11e-06	4.01e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.09e-06	3.98e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.89e-06	3.79e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.69e-06	3.6e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.65e-06	3.56e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.44e-06	3.35e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	3.43e-06	3.34e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	2.84e-06	2.77e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.79e-06	2.72e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.75e-06	2.68e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.74e-06	2.67e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.53e-06	2.46e-05	CbGpPWpGaD
